Off-Label Use of Non-Vitamin K Antagonist Oral Anticoagulants

被引：1
|
作者：
van Vugt, Stijn P. G. [1 ]
Brouwer, Marc A. [1 ]
Verheugt, Freek W. A. [1 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, Geert Grootepl 10,Route 616,POB 9101, NL-6500 HB Nijmegen, Netherlands
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 69卷 / 20期
关键词：
OUTCOMES;
D O I：
10.1016/j.jacc.2017.01.073
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2577 / 2578
页数：3
相关论文
共 50 条
  • [1] Trends in Off-Label Indications of Non-Vitamin K Antagonist Oral Anticoagulants in Acute Coronary Syndrome
    Kaddoura, Rasha
    Orabi, Bassant
    Yassin, Mohamed A.
    Omar, Amr S.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (06)
  • [2] Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    van den Dries, Carline J.
    Pajouheshnia, Romin
    van den Ham, Hendrika A.
    Souverein, Patrick
    Moons, Karel G. M.
    Hoes, Arno W.
    Geersing, Geert-Jan
    van Doorn, Sander
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (02) : 751 - 761
  • [3] Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation
    Chan, Yi-Hsin
    Chao, Tze-Fan
    Chen, Shao-Wei
    Lee, Hsin-Fu
    Yeh, Yung-Hsin
    Huang, Ya-Chi
    Chang, Shang-Hung
    Kuo, Chi-Tai
    Lip, Gregory Y. H.
    Chen, Shih-Ann
    HEART RHYTHM, 2020, 17 (12) : 2102 - 2110
  • [4] Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes The ORBIT-AF II Registry
    Steinberg, Benjamin A.
    Shrader, Peter
    Thomas, Laine
    Ansell, Jack
    Fonarow, Gregg C.
    Gersh, Bernard J.
    Kowey, Peter R.
    Mahaffey, Kenneth W.
    Naccarelli, Gerald
    Reiffel, James
    Singer, Daniel E.
    Peterson, Eric D.
    Piccini, Jonathan P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (24) : 2597 - 2604
  • [5] Off-Label Underdosing or Overdosing of Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis
    Wu, Xiaojuan
    Hu, Linyan
    Liu, Jinjin
    Gu, Qiuping
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [6] Non-vitamin K antagonist oral anticoagulants and sport
    Romano, Silvio
    Salustri, Elisa
    Robles, Antonio G.
    Calo, Leonardo
    Penco, Maria
    Sciarra, Luigi
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (02): : 98 - 109
  • [7] Pattern and Impact of Off-label Underdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Who are Indicated for Standard Dosing
    Cho, Min Soo
    Yun, Ji Eun
    Park, Ji Jeong
    Kim, Yun Jung
    Lee, Jessie
    Kim, Hyungmin
    Park, Duk-Woo
    Nam, Gi-Byoung
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (09): : 1332 - 1338
  • [8] Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
    Malagu, Michele
    Longo, Filomena
    Marchini, Federico
    Sirugo, Paolo
    Capanni, Andrea
    Clo, Stefano
    Mari, Elisa
    Culcasi, Martina
    Bertini, Matteo
    BIOLOGY-BASEL, 2023, 12 (04):
  • [9] Non-vitamin K antagonist oral anticoagulants and heart failure
    Isnard, Richard
    Bauer, Fabrice
    Cohen-Solal, Alain
    Damy, Thibaud
    Donal, Erwan
    Galinier, Michel
    Hagege, Albert
    Jourdain, Patrick
    Leclercq, Christophe
    Sabatier, Remi
    Trochu, Jean-Noel
    Cohen, Ariel
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2016, 109 (11) : 641 - 650
  • [10] Reversal agents for non-vitamin K antagonist oral anticoagulants
    Levy, Jerrold H.
    Douketis, James
    Weitz, Jeffrey I.
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (05) : 273 - 281
12345